Amplification/overexpression of HER2 [human epidermal growth factor receptor, a.k.a., c-ErbB-2, (ERBB2)] is an important cause of sporadic breast cancer that occurs in approximately 30% of breast cancer. Here, ERBB2 is linked to breast cancer.